Over the past several years, focused research efforts have led to innovative surgical and transcatheter treatment options for aortic and mitral valve diseases. Now, these same efforts are on the rise in another area – the tricuspid valve – with the hope of achieving similar advantages and outcomes for patients.
Cardiologists on the medical staff at Baylor Scott & White The Heart Hospital – Plano are now using the first and only leadless pacemaker in the United States as a treatment option for patients with bradycardia. The Micra™ transcatheter pacing system (TPS) is about the size of a multivitamin, making it 93 percent smaller than traditional devices and the world’s smallest pacemaker.
The use of robotic technology has rapidly expanded in cardiac surgery, thoracic surgery and interventional cardiology over the last several years. As one of the state’s busiest robotic cardiothoracic surgery programs, Baylor Scott & White The Heart Hospital – Plano continues to invest in this growing field in order to provide even more minimally invasive options for patients.
The combined procedure is part of the hospital’s ongoing efforts to offer surgical options for patients with mitral annular calcification.
Baylor Scott & White The Heart Hospital – Plano recently completed the first successful combined procedure in Texas that included surgical implantation of transcatheter valve in native mitral annular calcification (SITRAL) and transcatheter aortic valve replacement (TAVR) using robotic technology.
Aortic dissections have been described as ticking time bombs—the sooner patients with this condition are treated, the better the outcome.
